Benzinga·4h ago·Globe NewswireMerck to Acquire Terns Pharmaceuticals for $6.7B to Bolster CML PortfolioMerck acquires Terns Pharmaceuticals for $6.7 billion to gain TERN-701, a novel leukemia treatment, at 31% premium valuation. MRKTERNacquisitionM&A
Benzinga··Globe Newswire